In the present study we demonstrate for the first time that MYC/MAX heterocomplex binds to the BCR promoter at four specific binding sites, leading to up-regulation of BCR and BCR/ABL1 at both transcriptional and protein levels in CML cell lines. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.